GE: The Biopharma Deal Is Nearing Completion
GE Sells Coveted BioPharma Unit to Pay Down $21 Billion in Crippling Debt
GE sells BioPharma business to CEO's former company
GE sells biopharma drug business to Danaher for $21.4 bn, Energy News, ET EnergyWorld
Debt-saddled GE sells off BioPharma business to Danaher for $21.4B - MedCity News
GE Healthcare float sunk in favour of Danaher deal | Evaluate
How to Trade GE Stock After Earnings Surge - TheStreet
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
GE Deal With Danaher Shows Culp Is All About the Balance Sheet - Bloomberg
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
General Electric Sells Biopharma Unit for $21 Billion | | 2news.com
GE sells biopharma unit to Danaher for $21.4B
GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher | GE News
Danaher buying GE Life Sciences biopharma business for $21.4 billion
Danaher absorbing GE's bioprocess biz in $21.4bn deal - BioProcess InternationalBioProcess International
GE sells biopharma drug business to Danaher for $21.4 billion
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
GE sells biopharma unit for US$21 billion | CTV News
GE agrees to sell BioPharma unit to Danaher for US$21.4 billion
GE to sell life sciences business for $21.4 billion | Crain's Chicago Business
GE To Sell Biopharma Business For $21.4bn – Independent Newspaper Nigeria
Danaher Corporation: General Electric to Sell Biopharma Unit for $21.4 Billion
General Electric — Wikipédia
GE sells BioPharma business to CEO's former company for $21.4 billion | CNN Business
General Electric selling Danaher Corporation, its biopharma business
GE to Sell Its Biotech Business to Danaher for $21 Billion - WSJ
